European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023
暂无分享,去创建一个
I. Zapardiel | M. Mirza | V. Vandecaveye | L. Woelber | D. Fischerová | S. Mahner | A. Redondo | A. van der Zee | G. Zannoni | S. Lax | C. Creutzberg | G. Garganese | A. Sturdza | E. Ulrikh | F. Planchamp | M. Oonk | A. Taylor | P. Baldwin | E. Guillot | D. Zach | Maaike H. M. Oonk
[1] B. Monk,et al. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. , 2022, Gynecologic oncology.
[2] G. Scambia,et al. The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis , 2022, Cancers.
[3] V. Chiantera,et al. Detection of sentinel lymph node in vulvar cancer using ^99mTc-labeled colloid lymphoscintigraphy, blue dye, and indocyanine-green fluorescence: a meta-analysis of studies published in 2010–2020 , 2022, Archives of Gynecology and Obstetrics.
[4] H. V. van Doorn,et al. Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study , 2022, BMC cancer.
[5] A. Italiano,et al. Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study. , 2022, Gynecologic oncology.
[6] Yonghong Luo,et al. Analysis of Short-Term Efficacy of Gasless Single-Port Laparoscopic Inguinal Lymphadenectomy Through Vulva Incision for Vulvar Cancer , 2022, Frontiers in Surgery.
[7] Kathy Han,et al. Postoperative management of vulvar cancer , 2022, International Journal of Gynecological Cancer.
[8] M. Gerken,et al. Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration , 2022, Journal of Cancer Research and Clinical Oncology.
[9] B. Monk,et al. Survival with Cemiplimab in Recurrent Cervical Cancer. , 2022, The New England journal of medicine.
[10] K. Matsuo,et al. Validation of the 2021 FIGO staging schema for advanced vulvar cancer , 2022, International Journal of Gynecological Cancer.
[11] K. Lindemann,et al. Early referral to a palliative team improves end-of-life care among gynecological cancer patients: a retrospective, population-based study , 2022, International Journal of Gynecological Cancer.
[12] S. Carletto,et al. The Impact of Vulvar Cancer on Psychosocial and Sexual Functioning: A Literature Review , 2021, Cancers.
[13] A. Nica,et al. The accuracy of intraoperative frozen section examination of sentinel lymph nodes in squamous cell cancer of the vulva. , 2021, Gynecologic oncology.
[14] G. Scambia,et al. Feasibility, indications and complications of SCIP flap for reconstruction after extirpative surgery for vulvar cancer , 2021, Journal of Plastic, Reconstructive & Aesthetic Surgery.
[15] G. Macchia,et al. The Radiotherapy Role in the Multidisciplinary Management of Locally Advanced Vulvar Cancer: A Multidisciplinary VulCan Team Review , 2021, Cancers.
[16] M. Beckmann,et al. Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study. , 2021, Gynecologic oncology.
[17] M. Cuello,et al. Cancer of the vulva: 2021 update , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[18] E. Sala,et al. Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR) , 2021, Insights into Imaging.
[19] B. Monk,et al. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. , 2021, The New England journal of medicine.
[20] H. Putter,et al. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] L. Kumar,et al. Adjuvant treatment in cervical, vaginal and vulvar cancer. , 2021, Best practice & research. Clinical obstetrics & gynaecology.
[22] B. Rai,et al. Practical aspects of palliative care & palliative radiotherapy in incurable cervical cancer , 2021, The Indian journal of medical research.
[23] B. van Triest,et al. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study. , 2021, Gynecologic oncology.
[24] L. Gianolli,et al. Clinical and prognostic 18F-FDG PET/CT role in recurrent vulvar cancer: a multicentric experience , 2021, Japanese Journal of Radiology.
[25] M. Kamdar,et al. Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population , 2021, JCO global oncology.
[26] L. Valentin,et al. Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[27] M. Kamdar,et al. Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering , 2021, JCO global oncology.
[28] C. Sessa,et al. Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population , 2021, JCO global oncology.
[29] Stella K Kang,et al. ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer. , 2021, Journal of the American College of Radiology : JACR.
[30] A. Perrone,et al. Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies , 2021, Cancers.
[31] T. Ignatov,et al. Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastases , 2021, Acta obstetricia et gynecologica Scandinavica.
[32] A. Perrone,et al. Quality of Life with Vulvar Carcinoma Treated with Palliative Electrochemotherapy: The ELECHTRA (ELEctroCHemoTherapy vulvaR cAncer) Study , 2021, Cancers.
[33] G. Scambia,et al. Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[34] H. Leonhardt,et al. Accuracy of computerized tomography in the preoperative evaluation of metastases in primary vulvar cancer - A population-based study. , 2021, Gynecologic oncology.
[35] M. Koual,et al. Diagnostic value of indocyanine green fluorescence guided sentinel lymph node biopsy in vulvar cancer: A systematic review. , 2021, Gynecologic oncology.
[36] E. Hartenbach,et al. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cervical Cancer. , 2021, Journal of palliative medicine.
[37] S. Beriwal,et al. Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer. , 2021, Gynecologic oncology.
[38] J. Pijnenborg,et al. Low incidence of pulmonary metastases in vulvar cancer patients: limited value of routine chest imaging based on a cohort study , 2020, BJOG : an international journal of obstetrics and gynaecology.
[39] T. Fehm,et al. The potential risk of contralateral non-sentinel groin node metastasis in women with early primary vulvar cancer following unilateral sentinel node metastasis: a single center evaluation in University Hospital of Düsseldorf , 2020, BMC Women's Health.
[40] P. Benedetti Panici,et al. Reducing the radicality of surgery for vulvar cancer: are smaller margins safe? , 2020, Minerva ginecologica.
[41] R. Pérez-Cuevas,et al. Association of supportive care needs and quality of patient‐centered cancer care with depression in women with breast and cervical cancer in Mexico , 2020, Psycho-oncology.
[42] N. Hacker,et al. The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study , 2020, Cancers.
[43] P. Benedetti Panici,et al. The V‐Y gluteal fold advancement flap: Outcomes following radical surgery for vulvar malignancies , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[44] W. E. Richards,et al. GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. , 2020, Gynecologic oncology.
[45] M. Kamdar,et al. Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer , 2020, International Journal of Gynecological Cancer.
[46] H. Putter,et al. Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial. , 2020, Gynecologic oncology.
[47] S. Beriwal,et al. Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate? , 2020, Gynecologic oncology.
[48] S. H. van der Burg,et al. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes. , 2020, Gynecologic oncology.
[49] L. Hoang,et al. A review of prognostic factors in squamous cell carcinoma of the vulva: Evidence from the last decade. , 2020, Seminars in diagnostic pathology.
[50] V. Master,et al. Inguinal lymph node dissection in the era of minimally invasive surgical technology. , 2020, Urologic oncology.
[51] Longwen Chen,et al. Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva. , 2020, Gynecologic oncology.
[52] R. Jach,et al. Prognostic factors in patients with vulvar cancer: the VULCAN study , 2020, International Journal of Gynecological Cancer.
[53] A. Schultheis,et al. Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis , 2020, Journal of Cancer Research and Clinical Oncology.
[54] K. Zalewski,et al. Radical vulvectomy with right gluteal and left medial thigh V-Y advancement flap reconstruction , 2020, Journal of the Turkish German Gynecological Association.
[55] A. Gadducci,et al. Locally advanced squamous cell carcinoma of the vulva: A challenging question for gynecologic oncologists. , 2020, Gynecologic oncology.
[56] F. Bray,et al. Geographic and temporal variations in the incidence of vulvar and vaginal cancers , 2020, International journal of cancer.
[57] G. Scambia,et al. Palliative electrochemotherapy in primary or recurrent vulvar cancer , 2020, International Journal of Gynecological Cancer.
[58] Lili Zhao,et al. Predictive Value of an Alternative Strategy for Measuring Depth and Size of Stage 1 Vulvar Squamous Cell Carcinoma , 2020, Journal of lower genital tract disease.
[59] C. Gilks,et al. Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma , 2020, Histopathology.
[60] D. Huntsman,et al. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status , 2020, Modern Pathology.
[61] G. Scambia,et al. Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph‐node status in women with vulvar cancer: MorphoNode study , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[62] B. Ataseven,et al. Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients , 2020, Archives of Gynecology and Obstetrics.
[63] S. Kehoe,et al. The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinoma. , 2020, Gynecologic oncology.
[64] A. Tranoulis,et al. Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis , 2019, International Journal of Gynecological Cancer.
[65] P. Kannisto,et al. Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden , 2019, International Journal of Gynecological Cancer.
[66] R. Wenham,et al. High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity. , 2019, Gynecologic oncology.
[67] C. Touboul,et al. Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[68] J. Machiels,et al. Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] T. Stéphanie,et al. Outcomes of the use of different vulvar flaps for reconstruction during surgery for vulvar cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[70] P. Hillemanns,et al. Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study. , 2019, Gynecologic oncology.
[71] H. Hollema,et al. Margin status revisited in vulvar squamous cell carcinoma. , 2019, Gynecologic oncology.
[72] E. Rossi,et al. Ultrasound‐guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study , 2019, Cancer cytopathology.
[73] E. Sartori,et al. Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[74] P. Bult,et al. Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls , 2019, Histopathology.
[75] Arwa Mohammad,et al. Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer. , 2019, Journal of minimally invasive gynecology.
[76] D. Mutch,et al. Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study. , 2019, Gynecologic oncology.
[77] K. Schmeler,et al. End-of-life symptoms and interventions among women with gynecologic cancers in a tertiary-care hospital in Thailand , 2019, International Journal of Gynecological Cancer.
[78] F. Ebner,et al. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases , 2019, Archives of Gynecology and Obstetrics.
[79] R. Gómez-Martinez,et al. Vulvar Cancer. , 2019, Obstetrics and gynecology clinics of North America.
[80] J. Lunceford,et al. T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] N. Rydzewski,et al. Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[82] D. Boll,et al. Surgical margins in squamous cell carcinoma, different for the vulva? , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[83] J. Inthout,et al. The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single‐centre study , 2018, BJOG : an international journal of obstetrics and gynaecology.
[84] R. Vaucher,et al. Triple flap technique for vulvar reconstruction. , 2018, Annales de chirurgie plastique et esthetique.
[85] P. Bult,et al. Vulvar cancer: Two pathways with different localization and prognosis. , 2018, Gynecologic oncology.
[86] C. Benedetto,et al. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma , 2018, Journal of gynecologic oncology.
[87] A. Le,et al. Endoscopy-assisted inguinal lymphadenectomy in vulvar cancer , 2018, Archives of Gynecology and Obstetrics.
[88] F. Demirkıran,et al. The Role of Pathological Margin Distance and Prognostic Factors After Primary Surgery in Squamous Cell Carcinoma of the Vulva , 2018, International Journal of Gynecologic Cancer.
[89] M. Kamdar,et al. Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis. , 2018, Gynecologic oncology.
[90] E. Miyagi,et al. Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care. , 2018, Anticancer research.
[91] S. de Sanjosé,et al. "Histological characteristics of HPV‐associated and ‐independent squamous cell carcinomas of the vulva: A study of 1,594 cases” , 2017, International journal of cancer.
[92] C. Marchetti,et al. Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: Evaluation of feasibility and morbidity of different surgical techniques. , 2017, Surgical oncology.
[93] H. Hollema,et al. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review. , 2017, Gynecologic oncology.
[94] Xuyin Zhang,et al. A Comparative Study of Video Endoscopic Inguinal Lymphadenectomy and Conventional Open Inguinal Lymphadenectomy for Treating Vulvar Cancer , 2017, International Journal of Gynecologic Cancer.
[95] Xiao Long,et al. Incidence of lower limb lymphedema after vulvar cancer , 2017, Medicine.
[96] B. Monk,et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) , 2017, The Lancet.
[97] S. Atreya. Referral Patterns of Gynecological Cancer Patients to a Palliative Medicine Unit: A 2 Years Retrospective Analysis , 2017, Indian journal of palliative care.
[98] J. Ordi,et al. Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance , 2017, Clinical Cancer Research.
[99] E. De Ponti,et al. 18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective? , 2017, Medicine.
[100] P. Grigsby,et al. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. , 2017, Gynecologic oncology.
[101] G. Scambia,et al. Versatility of pedicled anterolateral thigh flap in gynecologic reconstruction after vulvar cancer extirpative surgery , 2017, Microsurgery.
[102] A. Talhouk,et al. Human papillomavirus (HPV)‐independent vulvar squamous cell carcinoma has a worse prognosis than HPV‐associated disease: a retrospective cohort study , 2017, Histopathology.
[103] A. Buda,et al. Comparison of V-Y Advancement Flap Versus Lotus Petal Flap for Plastic Reconstruction After Surgery in Case of Vulvar Malignancies: A Retrospective Single Center Experience , 2017, Annals of plastic surgery.
[104] M. van Beurden,et al. A Prospective Assessment of Surgical Risk Factors in 114 Gluteal Fold Flap Reconstructions After Oncological Vulvoperineal Resection , 2017, Annals of plastic surgery.
[105] P. Thaker,et al. Yield of Cytology Surveillance After High-Grade Vulvar Intraepithelial Neoplasia or Cancer , 2017, Journal of lower genital tract disease.
[106] A. Nica,et al. Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors. , 2017, Gynecologic oncology.
[107] G. Scambia,et al. The video endoscopy inguinal lymphadenectomy for vulvar cancer: A pilot study. , 2017, Taiwanese journal of obstetrics & gynecology.
[108] D. Furniss,et al. Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency? , 2017, Microsurgery.
[109] P. Mallmann,et al. Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: A pooled Reanalysis. , 2017, European journal of obstetrics, gynecology, and reproductive biology.
[110] C. Haie-meder,et al. Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma. , 2017, Brachytherapy.
[111] R. Rouzier,et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer , 2017, International Journal of Gynecologic Cancer.
[112] T. Fehm,et al. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. , 2016, European journal of cancer.
[113] Hanzi Xu,et al. Video Endoscopic Inguinal Lymphadenectomy via 3-Incision Lateral Approach for Vulvar Cancers: Our Preliminary Outcome of 37 Cases , 2016, International Journal of Gynecologic Cancer.
[114] K. Gaarenstroom,et al. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. , 2016, Critical reviews in oncology/hematology.
[115] T. Stijnen,et al. Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter? , 2016, European journal of cancer.
[116] E. Burandt,et al. Patterns of distant metastases in vulvar cancer. , 2016, Gynecologic oncology.
[117] 亮 喜多川. Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. , 2016 .
[118] G. Scambia,et al. Surgical therapy of vulvar cancer: how to choose the correct reconstruction? , 2016, Journal of gynecologic oncology.
[119] V. Casoli,et al. Modified Gluteal Fold V-Y Advancement Flap for Reconstruction After Radical Vulvectomy , 2016, International Journal of Gynecologic Cancer.
[120] M. Cheng,et al. Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection , 2016, Journal of surgical oncology.
[121] J. Lou,et al. Prognostic Value of Overexpressed p16INK4a in Vulvar Cancer: A Meta-Analysis , 2016, PloS one.
[122] A. V. D. Van Der Zee,et al. Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible. , 2016, Gynecologic oncology.
[123] F. Berger,et al. 32. Deutscher Krebskongress Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ, Berlin, 24.-27. Februar 2016: Abstracts , 2016, Oncology Research and Treatment.
[124] T. Ignatov,et al. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins , 2016, Journal of Cancer Research and Clinical Oncology.
[125] S. Rawal,et al. Robotic-Assisted Video Endoscopic Inguinal Lymphadenectomy in Carcinoma Vulva: Our Experiences and Intermediate Results , 2016, International Journal of Gynecologic Cancer.
[126] B. van Calster,et al. Subjective ultrasound assessment, the ADNEX model and ultrasound‐guided tru‐cut biopsy to differentiate disseminated primary ovarian cancer from metastatic non‐ovarian cancer , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[127] C. Faloppa,et al. How important is the pathological margin distance in vulvar cancer? , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[128] E. Bruera,et al. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. , 2015, Gynecologic oncology.
[129] A. Günthert,et al. Should Groin Recurrence Still Be Considered as a Palliative Situation in Vulvar Cancer Patients?: A Brief Report , 2015, International Journal of Gynecologic Cancer.
[130] Wei Zhang,et al. Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignancies , 2015, BMC Cancer.
[131] A. Perrone,et al. Palliative electro‐chemotherapy in elderly patients with vulvar cancer: A phase II trial , 2015, Journal of surgical oncology.
[132] S. Post,et al. Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma , 2015, The American journal of surgical pathology.
[133] L. Jacob,et al. Potential delay in the diagnosis of vulvar cancer and associated risk factors in women treated in German gynecological practices , 2015, Oncotarget.
[134] M. Rajagopalan,et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. , 2015, Gynecologic oncology.
[135] N. Takeshima,et al. Vulvar Reconstruction Following Surgery for Vulvar Cancer Using a Stepladder V-Y Advancement Medial Thigh Flap , 2015, International Journal of Gynecologic Cancer.
[136] V. Bae-Jump,et al. Comprehensive care in gynecologic oncology: The importance of palliative care. , 2015, Gynecologic oncology.
[137] W. Bechstein,et al. Abdominoperineal Excisions in the Treatment Regimen for Advanced and Recurrent Vulvar Cancers—Analysis of a Single-Centre Experience , 2015, Indian Journal of Surgery.
[138] R. Berkowitz,et al. Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? , 2015, Gynecologic oncology.
[139] J. Inthout,et al. Clitoral involvement of squamous cell carcinoma of the vulva: localization with the worst prognosis. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[140] G. Kotronoulas,et al. A systematic review of the supportive care needs of women living with and beyond cervical cancer. , 2015, Gynecologic oncology.
[141] C. Lefkowits,et al. Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. , 2015, Gynecologic oncology.
[142] P. Bult,et al. An alternative way to measure the depth of invasion of vulvar squamous cell carcinoma in relation to prognosis , 2015, Modern Pathology.
[143] S. Beriwal,et al. The Effect of Groin Treatment Modality and Sequence on Clinically Significant Chronic Lymphedema in Patients With Vulvar Carcinoma , 2015, International Journal of Gynecologic Cancer.
[144] D. Bodurka,et al. Overall survival after pelvic exenteration for gynecologic malignancy. , 2014, Gynecologic oncology.
[145] A. Bryant,et al. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. , 2014, The Cochrane database of systematic reviews.
[146] C. Lefkowits,et al. Predictors of palliative care consultation on an inpatient gynecologic oncology service: are we following ASCO recommendations? , 2014, Gynecologic oncology.
[147] H. Jeon,et al. Short-course palliative radiotherapy for uterine cervical cancer , 2013, Radiation oncology journal.
[148] A. Sutton,et al. Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation. , 2013, Health technology assessment.
[149] W. Hofmann,et al. Characteristics, Treatment and Prognostic Factors of Patients with Gynaecological Malignancies Treated in a Palliative Care Unit at a University Hospital , 2013, Oncology Research and Treatment.
[150] P. Whiting,et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. , 2013, Health technology assessment.
[151] G. Treglia,et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. , 2013, Gynecologic oncology.
[152] L. Woelber,et al. Management of patients with vulvar cancer: a perspective review according to tumour stage , 2013, Therapeutic advances in medical oncology.
[153] U. Matulonis,et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. , 2012, Gynecologic oncology.
[154] Amy P Abernethy,et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[155] L. Woelber,et al. Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant Treatment , 2012, International Journal of Gynecologic Cancer.
[156] F. Amant,et al. Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced, Recurrent, or Metastatic Vulvar Cancer , 2012, International Journal of Gynecologic Cancer.
[157] H. Michael,et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. , 2011, Gynecologic oncology.
[158] G. Thomas,et al. Palliative radiotherapy for cervical carcinoma, a systematic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[159] M. Zikan,et al. Ultrasound‐guided tru‐cut biopsy of abdominal and pelvic tumors in gynecology , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[160] Alona Muzikansky,et al. Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.
[161] L. Selvaggi,et al. Groin recurrence in carcinoma of the vulva: management and outcome. , 2010, European journal of cancer care.
[162] F. Gissi,et al. Cisplatin and Vinorelbine Chemotherapy in Recurrent Vulvar Carcinoma , 2009, Oncology.
[163] E. Crosbie,et al. The management of vulval cancer. , 2009, Cancer treatment reviews.
[164] I. Vergote,et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[165] V. Gebski,et al. Outcome and Patterns of Recurrence for International Federation of Gynecology and Obstetrics (FIGO) Stages I and II Squamous Cell Vulvar Cancer , 2009, Obstetrics and gynecology.
[166] A. Iafrate,et al. Decreased survival in EGFR gene amplified vulvar carcinoma. , 2008, Gynecologic oncology.
[167] P. Maciejewski,et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. , 2008, JAMA.
[168] D. Heron,et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. , 2008, Gynecologic oncology.
[169] Achim Schneider,et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[170] M. Heatley. Dissection and reporting of the organs of the female genital tract , 2007, Journal of Clinical Pathology.
[171] M. Zikan,et al. Ultrasound- guided tru- cut biopsy in the management of advanced abdomino- pelvic tumors , 2007, International Journal of Gynecologic Cancer.
[172] G. D. de Bock,et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. , 2006, Gynecologic oncology.
[173] H. V. van Doorn,et al. Neoadjuvant chemoradiation for advanced primary vulvar cancer. , 2006, The Cochrane database of systematic reviews.
[174] M. J. Webb,et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. , 2005, Gynecologic oncology.
[175] H. Hollema,et al. The value of routine follow‐up in patients treated for carcinoma of the vulva , 2003, Cancer.
[176] C. Dykewicz. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[177] M. Nooij,et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. , 2001, Gynecologic oncology.
[178] A. Gadducci,et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva , 2000, Cancer.
[179] G. Montana,et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. , 1998, International journal of radiation oncology, biology, physics.
[180] Thomas J. Smith,et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[181] S. Beriwal,et al. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base. , 2017, International journal of radiation oncology, biology, physics.
[182] S. Shrivastava,et al. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience. , 2017, Brachytherapy.
[183] D. Provencher,et al. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. , 2016, Gynecologic oncology.
[184] D. Forner,et al. Exenteration in the treatment of Stage III/IV vulvar cancer. , 2012, Gynecologic oncology.
[185] S. Tumolo,et al. Cisplatin-gemcitabine as palliative chemotherapy in advanced squamous vulvar carcinoma: report of two cases. , 2012, European journal of gynaecological oncology.
[186] J. Thigpen. Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study , 2010 .
[187] J. Monaghan,et al. Does long-term follow-up have a role for node negative squamous carcinoma of the vulva? The Gateshead experience. , 2001, European journal of gynaecological oncology.
[188] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[189] P. Benedetti Panici,et al. Reducing the radicality of surgery for vulvar cancer: are smaller margins safer? , 2022, Minerva Obstetrics and Gynecology.